Abstract
Postoperative peritoneal adhesions develop after almost any abdominal operation and are the leading cause of recurrent adhesive intestinal obstruction. Widely used antiadhesion barriers have been associated with a number of adverse effects, including immunosuppression, allergic reactions and an increased incidence of intra-abdominal infectious complications. An ideal agent should not interrupt the natural protective adhesion process but should accelerate adhesion resorption, which justifies the experimental search for new biocompatible materials.
References

This work is licensed under a Creative Commons Attribution 4.0 International License.
